Keck School Faculty

Mallory Chavannes

Mallory Chavannes

Assistant Professor of Clinical Pediatrics
Pediatrics
4650 Sunset Blvd. Off Campus Los Angeles

SC-CTSI: Mentored Career Development in Clinical and Translational Research, 2020-2023

American Gastroenterology Association: Pfizer Pilot Research Award, 2020-2021

J Can Assoc Gastroenterol. 2020 Oct; 3(5):216-221. . View in PubMed

Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis J Crohns Colitis. 2020 Jan 01; 14(1):46-52. . View in PubMed

Management of Paediatric Patients With Medically Refractory Crohn's Disease Using Ustekinumab: A Multi-Centred Cohort Study J Crohns Colitis. 2019 Apr 26; 13(5):578-584. . View in PubMed

Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease BMJ Open. 2019 04 14; 9(4):e027043. . View in PubMed

Diagnosis by peritoneal scintigraphy of peritoneal dialysis-associated hydrothorax in an infant Perit Dial Int. 2014 Jan-Feb; 34(1):140-3. . View in PubMed

The need for ongoing monitoring of adherence to access targets Pediatr Nephrol. 2013 May; 28(5):831-2. . View in PubMed

Location of parathyroid adenomas: 7-year experience J Otolaryngol Head Neck Surg. 2010 Oct; 39(5):551-4. . View in PubMed

Dr. Chavannes received her MD degree at McGill University, Montreal, Quebec, Canada, in 2011. She then completed her residency in pediatric at the University of Western Ontario, in London, Ontario, Canada, in 2014. She successfully completed her pediatric gastroenterology fellowship at the University of Montreal, Quebec, Canada in 2016. Dr. Chavannes completed her Masters of Health Science in Epidemiology and one year of Advanced Inflammatory Bowel Disease Fellowship at the University of British Columbia, Vancouver, Canada in December 2017.

Dr. Chavannes, research focus has been on the evaluation of therapies in inflammatory bowel diseases. Her paper on “The Assessment of the use of therapeutic drug monitoring of Adalimumab during maintenance therapy in children with Inflammatory Bowel Disease” was presented both at ECCO (European Crohn’s & Colitis Organization) meeting in Barcelona in 2017 and at DDW in Chicago in May 2017. Her research interest is in finding non-invasive ways of monitoring disease activity in children with inflammatory bowel disease.
Powered by SC CTSI
Go to Top